Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthew Deitz"'
Autor:
Sunny Guin, Bobby K Liaw, Tomi Jun, Kristin Ayers, Bonny Patel, Timmy O'Connell, Matthew Deitz, Michael Klein, Tommy Mullaney, Tony Prentice, Scott Newman, Marc Fink, Xiang Zhou, Eric E Schadt, Rong Chen, William K Oh
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0264800 (2022)
BackgroundUpfront docetaxel or novel hormonal agents (NHA) such as abiraterone and enzalutamide have become the standard of care for metastatic hormone sensitive prostate cancer (mHSPC). We evaluated real-world management of patients treated with the
Externí odkaz:
https://doaj.org/article/506615a56a514357b3ce831d397c5b43
Autor:
Sunny Guin, Tomi Jun, Vaibhav G. Patel, Kristin L. Ayers, Matthew Deitz, Yuqin Cai, Xiang Zhou, Che-Kai Tsao, William K. Oh, Rong Chen, Bobby C. Liaw
Publikováno v:
JCO Clin Cancer Inform
PURPOSE Data quality and standardization remain a challenge when analyzing real-world clinical data. We built a clinical research database, using machine learning and natural learning processing, and investigated factors influencing testosterone reco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca59ec3f2cf47c36b04e241ca05ad766
https://pubmed.ncbi.nlm.nih.gov/35696627
https://pubmed.ncbi.nlm.nih.gov/35696627
Autor:
Tony Prentice, Sunny Guin, Scott Newman, Timmy O’Connell, William Oh, Tomi Jun, Kristin L. Ayers, Bobby K. Liaw, Marc Y. Fink, Bonny Patel, Matthew Deitz, Eric E. Schadt, Tommy Mullaney, Michael W. Klein, Rong Chen, Xiang Zhou
Background: Upfront docetaxel or novel hormonal agents (NHA) such as abiraterone and enzalutamide have become the standard of care for metastatic hormone sensitive prostate cancer (mHSPC). However, data comparing the efficacy of docetaxel and NHAs in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c94d5454e3dafb5b352608cfedb4c133
https://doi.org/10.21203/rs.3.rs-659032/v1
https://doi.org/10.21203/rs.3.rs-659032/v1
Autor:
Dan Li, Rong Chen, Zongzhi Liu, Tony Prentice, Scott B. Jones, Xiaoyan Wang, Kyeryoung Lee, Christopher Gilman, Eric E. Schadt, Arielle Redfern, Tommy Mullaney, Yun Mai, Matthew Deitz, Xiang Zhou, Ying Ru, Meng Ma, Yunrou Gong
Publikováno v:
Journal of Clinical Oncology. 38:e14062-e14062
e14062 Background: Real world evidence generated from electronic health records (EHRs) is playing an increasing role in health care decisions. It has been recognized as an essential element to assess cancer outcomes in real-world settings. Automatica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38e71fca23984f08f7629b7c5af4d529
https://doi.org/10.1200/jco.2020.38.15_suppl.e14062
https://doi.org/10.1200/jco.2020.38.15_suppl.e14062